Haemonetics Corp Earnings

Haemonetics Corp’s revenue fell -5.27% since last year same period to $327.32Mn in the Q3 2025. On a quarterly growth basis, Haemonetics Corp has generated 1.84% jump in its revenue since last 3-months.

Haemonetics Corp’s net profit jumped 14.34% since last year same period to $38.68Mn in the Q3 2025. On a quarterly growth basis, Haemonetics Corp has generated 13.67% jump in its net profits since last 3-months.

Haemonetics Corp’s net profit margin jumped 20.7% since last year same period to 11.82% in the Q3 2025. On a quarterly growth basis, Haemonetics Corp has generated 11.62% jump in its net profit margins since last 3-months.

Haemonetics Corp’s earning per share (EPS) estimates for the current quarter stand at 1.25 - a 12.61% jump from last quarter’s estimates.

Haemonetics Corp’s earning per share (EPS) estimates for the current year stand at 1.25.

Haemonetics Corp’s earning per share (EPS) jumped 92.42% since last year same period to 1.27 in the Q3 2025. This indicates that the Haemonetics Corp has generated 92.42% annual rate of jump in its earning per share (EPS) in the last 4 quarters.